<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>input-it</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<h1 class="erlasstitel botschafttitel ">Ordinanza del DEFR <br>concernente la costituzione di scorte obbligatorie di medicamenti</h1>
<p class="man-template-datum-aend ">Modifica del 24 novembre 2023</p>
</div>
<div id="preamble">
<p class="man-template-autor ">Il Dipartimento federale dell’economia, della formazione e della ricerca (DEFR)</p>
<p class="man-template-verb ">ordina:</p>
</div>
<main id="maintext"><section id="lvl_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I">I</a>
</h1>
<div class="collapseable">
<p class="absatz ">L’ordinanza del DEFR del 20 maggio 2019<sup><a href="#fn-d8e21" id="fnbck-d8e21">1</a></sup> concernente la costituzione di scorte obbligatorie di medicamenti è modificata come segue:</p>
<p class="verweisartkursiv man-font-style-italic ">Art. 6, rubrica, e cpv. 1</p>
<p class="absatz man-text-align-left ">Volume delle scorte obbligatorie di analgesici, vaccini e medicamenti oncologici della medicina umana</p>
<p class="absatz "><sup>1</sup> Il quantitativo totale dei seguenti prodotti di cui all’allegato 1 numeri 4–5<i>a</i> copre il fabbisogno medio della popolazione svizzera per la durata indicata:</p>
<dl>
<dt>a. </dt>
<dd>analgesici: 3 mesi;</dd>
<dt>b. </dt>
<dd>vaccini: 4 mesi;</dd>
<dt>c. </dt>
<dd>medicamenti oncologici: 3 mesi.</dd>
</dl>
<p class="verweisartkursiv man-font-style-italic ">Art. 6a cpv. 1</p>
<p class="absatz "><sup>1</sup> Il quantitativo totale delle merci depositate di cui all’allegato 1 numero 5<i>b</i> copre il fabbisogno medio della popolazione svizzera per tre mesi.</p>
<div class="footnotes"><p id="fn-d8e21"><sup><a href="#fnbck-d8e21">1</a></sup><sup></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2019/351" target="_blank">RS <b>531.215.311</b></a></p></div>
</div></section><section id="lvl_II"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_II">II</a>
</h1>
<div class="collapseable"><p class="absatz ">Gli allegati 1 e 2 sono modificati secondo la versione qui annessa.</p></div></section><section id="lvl_III"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_III">III</a>
</h1>
<div class="collapseable">
<p class="absatz ">La presente ordinanza entra in vigore il 15 gennaio 2024.</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<td>
					
					<p class="unterschriftenfi1 ">24 novembre 2023</p>
				</td>
				<td>
					
					<p class="unterschriftenfi1 ">Dipartimento federale dell’economia, della formazione e della ricerca:</p>
					<p class="unterschriftenfi ">Guy Parmelin</p>
				</td>
			</tr>
		</table></div>
</div></section></main><div id="annex">
<section id="annex_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1">Allegato 1</a>
</h1>
<div class="collapseable">
<p class="titelanhtext ">(art. 1)</p>
<section id="annex_1/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1">Merci secondo l’articolo 1</a>
</h2>
<div class="collapseable">
<p class="verweisartkursiv man-font-style-italic ">N. 4 e 5a–6</p>
<section id="annex_1/lvl_u1/lvl_4"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_4">4 Analgesici della medicina umana</a>
</h3>
<div class="collapseable"> <p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Codice ATC</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Designazione della merce</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Osservazioni</p>
				</th>
			</tr>
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-krpr ">N01AH06</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-krpr ">remifentanil</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-krpr "></p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">morfina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">idromorfone </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ossicodone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA51</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">morfina, combinazioni</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA55</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ossicodone e naloxone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">fentanile</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AC52</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">metadone, combinazioni </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">senza psicofarmaci</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">buprenorfina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">morfina e spasmolitici</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AG04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">idromorfone e spasmolitici</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">acido acetilsalicilico, incl. acetilsalicilato di lisina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N07BC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">metadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">N07BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">levometadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
		</table></div>
</div></section><section id="annex_1/lvl_u1/lvl_5_a"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_5_a">5<span class="man-font-weight-normal"><i>a</i></span> Medicamenti oncologici della medicina umana</a>
</h3>
<div class="collapseable"> <p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Codice ATC</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Designazione della merce</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Osservazioni</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">melfalan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">metotrexato</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">forme parenterali </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tioguanina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">citarabina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">gemcitabina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">etoposide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CE02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">irinotecano</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vecchio codice ATC: L01XX19</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01DB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">doxorubicina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">non liposomiale</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cisplatino</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">carboplatino</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oxaliplatino</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tamoxifene</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L03AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vaccino BCG</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
		</table></div>
</div></section><section id="annex_1/lvl_u1/lvl_5_b"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_5_b">5<span class="man-font-weight-normal"><i>b</i></span> Altri medicamenti della medicina umana</a>
</h3>
<div class="collapseable"> <p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Codice ATC</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Designazione della merce</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Osservazioni</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AD02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">alteplasi</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dosaggio &gt; 2 mg</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">noradrenalina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dobutamina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA24</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">adrenalina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">autoiniettori</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C03CA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">furosemide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">H01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ossitocina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M03AC09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">rocuronio</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01AX10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">propofol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08BA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">mezzi di contrasto radiologici contenenti solfato di bario</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08DA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">mezzi di contrasto per ultrasonologia</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
		</table></div>
</div></section><section id="annex_1/lvl_u1/lvl_6"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_6">6 Antinfettivi della medicina veterinaria</a>
</h3>
<div class="collapseable"> <p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Codice ATCve*t</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf "></p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Designazione della merce</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QA07A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">neomicina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AA10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">colistina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AA51</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">neomicina, combinazioni</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sulfaguanidina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QA07AB20</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sulfonamide, combinazioni</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QG51A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QG51AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ossitetraciclina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QG51AA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tetraciclina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QG51AA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">gentamicina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QG51AA05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cefapirina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tetraciclina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01B</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">amfenicoli</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01C</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">antibiotici beta-lattamici, penicillina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01D</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">altri antibiotici beta-lattamici</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01E</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sulfonamidi e trimetoprima</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01F</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">macrolidi e lincosamidi</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01G</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">aminoglicosidi</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01M</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">chinoloni</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01R</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">combinazioni di antibiotici e/o chemioterapici</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ01X</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QJ01XQ01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tiamulina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">QJ01XQ02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">valnemulina</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ51C</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">antibiotici beta-lattamici, penicillina per uso intramammario</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ51D</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">altri antibiotici beta-lattamici per uso intramammario</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">QJ51R</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">combinazioni di antibiotici per uso intramammario</p>
				</td>
			</tr>
			<tr>
				
				<td colspan="3"><dl>
<dt>* </dt>
<dd>Il codice ATCvet (<i>Anatomical Therapeutic Chemical Classification system for veterinary medicinal products</i>) può essere consultato in inglese (versione ufficiale) sul sito dell’OMS (WHO <i>Collaborating Centre for Drug Statistics Methodology</i>) all’indirizzo seguente: <a href="https://www.whocc.no/atcvet/atcvet_index/" target="_blank">
							www.whocc.no/ATCvet
						</a> &gt; ATCvet Index.</dd>
</dl></td>
			</tr>
		</table></div>
</div></section>
</div></section>
</div></section><section id="annex_2"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2">Allegato 2</a>
</h1>
<div class="collapseable">
<p class="titelanhtext ">(art. 2)</p>
<section id="annex_2/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1">Esonero dall’obbligo di concludere un contratto per la costituzione di scorte obbligatorie</a>
</h2>
<div class="collapseable">
<p class="verweisartkursiv man-font-style-italic ">N. 2</p>
<section id="annex_2/lvl_u1/lvl_2"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1/lvl_2">2 Antinfettivi della medicina veterinaria</a>
</h3>
<div class="collapseable"> <p class="absatz ">Può essere esonerato dall’obbligo di concludere un contratto per la costituzione di scorte obbligatorie chi, per anno civile, immette in commercio quantitativi di principi attivi inferiori ai limiti sotto indicati:</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf man-text-align-right ">Forma       </p>
					<p class="man-template-tab-kpf "><br>Gruppo di principi attivi</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Trattamento di singoli animali</p>
					<p class="man-template-tab-kpf ">chilogrammi</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Trattamento di allevamento (premiscela di medicamenti)</p>
					<p class="man-template-tab-kpf ">chilogrammi</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">1000/2000 – beta-lattamici</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">50</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">200</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         3000 – cloramfenicolo</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">20</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">–</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         4000 – tetraciclina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">20</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">200</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         5000 – macrolidi</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">200</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">      9XXX – altri antibiotici</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">25</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         9500 – aminoglicosidi</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">5</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">25</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">         9900 – chinolone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">50</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">25</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class="man-template-tab-krpr ">       11000 – sulfonamidi / trimetoprima</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-text-align-center ">25</p>
				</td>
			</tr>
		</table></div>
</div></section>
</div></section>
</div></section>
</div>
</div></body>
</html>
